AdvisorShares MSOS Daily Leveraged ETF (MSOX)

Wall Street was moderately upbeat last week.

Cannabis ETFs are experiencing one of their most dynamic years yet, driven by significant regulatory shifts. The Department of Health and Human Services‘ recommendation to reclassify cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act marks a pivotal moment. This change, coupled with growing Congressional suppo...

These cannabis stocks and ETFs stand to benefit if the proposed rescheduling of the substance takes place.